CCDC 2123645: Experimental Crystal Structure Determination
Justin A. Newman(Merck & Co., Inc., Rahway, NJ, USA (United States)), Alfred Y. Lee(Merck & Co., Inc., Rahway, NJ, USA (United States)), Luca Iuzzolino(Merck & Co., Inc., Rahway, NJ, USA (United States)), Peter Orth, Jessica F. Bruhn(NanoImaging Services), Mélissa Tan(Merck & Co., Inc., Rahway, NJ, USA (United States))
Cited by 0
Related Papers
Report on the sixth blind test of organic crystal structure prediction methods
|Acta Crystallographica Section B Structural Science Crystal Engineering and Materials|2016|606
Discovery of the 3-Imino-1,2,4-thiadiazinane 1,1-Dioxide Derivative Verubecestat (MK-8931)–A β-Site Amyloid Precursor Protein Cleaving Enzyme 1 Inhibitor for the Treatment of Alzheimer’s Disease
|Journal of Medicinal Chemistry|2016|165
Mechanism of Action and Epitopes of Clostridium difficile Toxin B-neutralizing Antibody Bezlotoxumab Revealed by X-ray Crystallography
|Journal of Biological Chemistry|2014|138
Discovery of an Orally Available, Brain Penetrant BACE1 Inhibitor That Affords Robust CNS Aβ Reduction
|ACS Medicinal Chemistry Letters|2012|99